154 related articles for article (PubMed ID: 750129)
1. A comparison of the chemosensitivity of murine tumours in vivo and in cell culture.
Bullen BR; Russell CW; Giles GR
Clin Oncol; 1978 Sep; 4(3):265-72. PubMed ID: 750129
[No Abstract] [Full Text] [Related]
2. Attempted drug-tumor sensitivity matching using diffusion chamber-cultivated cells.
Mason BH; Cain BF
Cancer Treat Rep; 1978 Dec; 62(12):2035-43. PubMed ID: 751713
[No Abstract] [Full Text] [Related]
3. Proceedings: A comparison of tumour sensitivity to cytostatic agents during in vivo and in vitro culture.
Bullen BR; Russell CW; Giles GR
Br J Surg; 1976 Aug; 63(8):660. PubMed ID: 953488
[No Abstract] [Full Text] [Related]
4. A novel camptothecin analog with enhanced antitumor activity.
Yount G; Yang Y; Wong B; Wang HJ; Yang LX
Anticancer Res; 2007; 27(5A):3173-8. PubMed ID: 17970058
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of chemosensitivity in the 6-day subrenal capsule assay].
Inoue K
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2423-30. PubMed ID: 3619455
[TBL] [Abstract][Full Text] [Related]
6. Screening data from the Cancer Chemotherapy National Service Center Screening Laboratories. XXI.
Leiter J; Abbott BJ; Schepartz SA
Can Res Suppl; 1964 Dec; ():1093-353. PubMed ID: 5878218
[No Abstract] [Full Text] [Related]
7. [Type A adenocarcinoma grafted into C3H/he-M mice subjected to treatment with various antineoplastic agents. I. Biological study].
Flores JM; Gallego E; Castaño M; Gallego A
Rev Esp Oncol; 1983; 30(3):337-59. PubMed ID: 6571377
[TBL] [Abstract][Full Text] [Related]
8. Screening data from the Cancer Chemotherapy National Service Center Screening Laboratories. XV.
Leiter J; Abbott BJ; Bourke AR; Schepartz SA; Wodinsky I
Cancer Res; 1963 Sep; 23(8 Pt 2):1483-729. PubMed ID: 5878214
[No Abstract] [Full Text] [Related]
9. Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors.
Corbett TH; Griswold DP; Mayo JG; Laster WR; Schabel FM
Cancer Res; 1975 Jun; 35(6):1568-73. PubMed ID: 1131824
[TBL] [Abstract][Full Text] [Related]
10. Nucleoside analogues: 8. Some isomers of B.3839, the original 5-fluorouracil/nitrosourea molecular combination, and their effect on colon, breast and lung tumours in mice.
McElhinney RS; McCormick JE; Bibby MC; Double JA; Atassi G; Dumont P; Pratesi G; Radacic M
Anticancer Drug Des; 1989 Jun; 4(1):1-20. PubMed ID: 2757750
[TBL] [Abstract][Full Text] [Related]
11. Design and evaluation of combination chemotherapy trials in experimental animal tumor systems.
Corbett TH; Griswold DP; Wolpert MK; Venditti JM; Schabel FM
Cancer Treat Rep; 1979 May; 63(5):799-801. PubMed ID: 455319
[No Abstract] [Full Text] [Related]
12. Glucan:inhibition of tumor growth and enhancement of survival in four syngeneic murine tumor models.
Di Luzio NR; McNamee R; Browder WI; Williams D
Cancer Treat Rep; 1978 Nov; 62(11):1857-66. PubMed ID: 728903
[No Abstract] [Full Text] [Related]
13. Nitrosoureas: a review of experimental antitumor activity.
Schabel FM
Cancer Treat Rep; 1976 Jun; 60(6):665-98. PubMed ID: 782694
[TBL] [Abstract][Full Text] [Related]
14. [Experimental study on the establishment of a mammary adenocarcinoma MA--737 (author's transl)].
Sun WY; Ma KS; Guan JF
Zhonghua Zhong Liu Za Zhi; 1980 Sep; 2(3):168-73. PubMed ID: 7227180
[No Abstract] [Full Text] [Related]
15. Antitumor efficacy of PD115934 (NSC 366140) against solid tumors of mice.
LoRusso P; Wozniak AJ; Polin L; Capps D; Leopold WR; Werbel LM; Biernat L; Dan ME; Corbett TH
Cancer Res; 1990 Aug; 50(16):4900-5. PubMed ID: 2165850
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of chemosensitivity against a human breast cancer xenograft (MX-1) with the subrenal capsule assay in BDF1 mice].
Inoue K; Wang Y; Tada A; Ueno K; Kojima K; Ogawa M
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1644-50. PubMed ID: 4026333
[TBL] [Abstract][Full Text] [Related]
17. [Type A adenocarcinoma grafted into C3H/he mice subjected to treatment with various antineoplastic agents. II. Histopathological and ultrastructural study].
Flores JM; Gallego E; Castaño M; González JL
Rev Esp Oncol; 1983; 30(3):361-78. PubMed ID: 6571378
[TBL] [Abstract][Full Text] [Related]
18. Body burden of cancer in relationship to therapeutic outcome: consideration of preclinical evidence.
Griswold DP
Cancer Treat Rep; 1986 Jan; 70(1):81-6. PubMed ID: 3943116
[No Abstract] [Full Text] [Related]
19. A modified screening system to select new cytostatic drugs.
Kraemer HP; Sedlacek HH
Behring Inst Mitt; 1984 May; (74):301-28. PubMed ID: 6383326
[No Abstract] [Full Text] [Related]
20. Approaches to combination chemotherapy in rat, mouse, and hamster tumors.
Griswold DP; Dykes DJ; Kelley CA; Roberts BJ; Dominick CA
Cancer Chemother Rep 2; 1974 Mar; 4(1):99-108. PubMed ID: 4524043
[No Abstract] [Full Text] [Related]
[Next] [New Search]
